1. Ikemoto, F., Y. Hirota enS. Iwata (1974a) General pharmacological properties ofi-hydroxy-5-oxo-5H-pyrido-[3,2-α]phenoxazine-3-carboxylic acid (catalin),Oyo Yakuri 8, 937–947.
2. Ikemoto, F., Y. Yamamoto, S. Fukui enS. Iwata (1974b) Toxicological studies oni-hydroxy-5-oxo-5H-pyrido-[3,2-α]phenoxazine-3-carboxylic acid (catalin),Oyo Yakuri 8, 911–936.
3. Japanese Drug Directory -Japta List (1968) Japan Pharmaceutical Traders' Association, Tokio, blz. 86.
4. Korte, I., O. Hockwin, H. Tullius enD. Diederich (1975a) Effect ofi-hydroxy-[3,2α]-5-phenoxazone-3-carboxylic acid on the reduced coenzymesNadh andNadph,Ophthalmic Res. 7, 440–446.
5. Korte, I., O. Hockwin, H. Tullius, D. Diederich, C. U. Steidtel enW. Scholl (1975b) Influence ofi-hydroxypyrido-[3,2α]-5-phenoxazone-3-carboxylic acid on the carbohydrate metabolism of the lens,Ophthalmic Res. 7, 282–291.